What is the first line treatment for hypertension (HTN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

First-Line Treatment for Hypertension

The first-line treatment for hypertension should include thiazide diuretics, ACE inhibitors, ARBs, or calcium channel blockers, with thiazide-like diuretics being preferred due to their proven efficacy in reducing cardiovascular events. 1, 2

Initial Medication Selection Algorithm

Step 1: Assess Patient Characteristics

  • For patients without comorbidities: Thiazide-like diuretics (chlorthalidone preferred over hydrochlorothiazide) 1, 3
  • For patients with albuminuria (UACR ≥30 mg/g): ACE inhibitor or ARB 1
  • For patients with diabetes and albuminuria: ACE inhibitor or ARB 1
  • For patients with coronary artery disease: ACE inhibitor or ARB 1, 2

Step 2: Consider Severity of Hypertension

  • BP 140/90-159/99 mmHg: Start with single agent 1
  • BP ≥160/100 mmHg: Start with two-drug combination 1

Medication Options and Evidence

Thiazide Diuretics

  • Preferred first-line agent with strongest evidence for reducing cardiovascular events 1, 3
  • Chlorthalidone is preferred over hydrochlorothiazide due to superior efficacy and outcomes 4, 3
  • Dosing: Chlorthalidone 12.5-25 mg daily 2

ACE Inhibitors

  • Effective for reducing cardiovascular events and mortality 1, 5
  • Particularly beneficial for patients with albuminuria, diabetes, or heart failure 1
  • Example: Lisinopril 10-40 mg daily 5

Angiotensin Receptor Blockers (ARBs)

  • Alternative to ACE inhibitors when not tolerated (less cough and angioedema) 1, 2
  • Equally effective for patients with albuminuria 1

Calcium Channel Blockers

  • Dihydropyridine type (e.g., amlodipine) is preferred 1, 6
  • Particularly effective in black patients 1
  • Dosing: Amlodipine 2.5-10 mg daily 6

Combination Therapy Considerations

For patients requiring multiple medications:

  • Effective combinations 1, 2:

    • Thiazide diuretic + ACE inhibitor or ARB
    • Calcium channel blocker + ACE inhibitor or ARB
    • Calcium channel blocker + thiazide diuretic
  • Avoid these combinations 1:

    • ACE inhibitor + ARB (increased adverse effects without additional benefit)
    • ACE inhibitor or ARB + direct renin inhibitor

Special Populations

Black Patients

  • Thiazide diuretics or calcium channel blockers are more effective than ACE inhibitors 1

Elderly Patients (≥65 years)

  • Start with lower doses and titrate carefully 2
  • Target BP <130 mmHg if tolerated 2

Resistant Hypertension

  • Add mineralocorticoid receptor antagonist (spironolactone 25-50 mg) when three-drug regimen including a diuretic fails 1, 2

Monitoring

  • For patients on ACE inhibitors, ARBs, or diuretics: Monitor serum creatinine/eGFR and potassium at least annually 1
  • Monitor for orthostatic hypotension, especially in elderly patients 2

Common Pitfalls to Avoid

  1. Using beta-blockers as first-line therapy (less effective than other classes for primary prevention) 1
  2. Using hydrochlorothiazide instead of chlorthalidone (chlorthalidone has better evidence) 3
  3. Combining ACE inhibitors with ARBs (increases adverse effects without additional benefit) 1
  4. Delaying combination therapy in patients with stage 2 hypertension (BP ≥160/100 mmHg) 1
  5. Not considering drug interactions (e.g., NSAIDs can reduce effectiveness of ACE inhibitors) 2

By following this evidence-based approach to selecting first-line antihypertensive therapy, clinicians can optimize blood pressure control and reduce cardiovascular morbidity and mortality in patients with hypertension.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.